Milestone Pharmaceuticals Q2 2026 Earnings Preview

Milestone Pharmaceuticals (MIST) is scheduled to announce Q2 earnings results on Wednesday, August 12th, before market open. - The consensus EPS Estimate is -$0.19 and the consensus Revenue Estimate is $0.82M - Over the last 3 months, EPS estimates have seen 1 upward revision...<

Milestone Pharmaceuticals (MIST) is scheduled to announce Q2 earnings results on Wednesday, August 12th, before market open. – The consensus EPS Estimate is -$0.19 and the consensus Revenue Estimate is $0.82M – Over the last 3 months, EPS estimates have seen 1 upward revision…

d 3 downward. Revenue estimates have seen 1 upward revision and 2 downward

Leave a Reply

Your email address will not be published. Required fields are marked *